3+ day, 10+ hour ago   (74+ words) Earn more while paying less with flexible yield options and zero hidden fees. Buy, sell, and convert crypto with zero platform fees. Keep more of your profit in your pocket. Watch your rewards compound automatically when you stake 50+ assets with…...

4+ day, 13+ hour ago   (165+ words) Eli Lilly has crushed broader equities in recent years. The company's leadership in the fast-growing GLP-1 market grants it attractive medium-term prospects. The stock can deliver competitive returns over the next five years. LLY Revenue (Annual) data by YCharts The…...

5+ day, 2+ hour ago   (130+ words) Why Did Newmont (NYSE:NEM) Slide Even As Gold Sits Near Record Highs? On September 2, 2026, ELI LILLY & Co executive Eric Dozier transferred 216 shares as a gift at $0 per share. Post-transaction, Dozier maintains ownership of 14,239 shares, reflecting the updated holdings of…...

6+ day, 5+ min ago   (280+ words) What's interesting is that Eli Lilly wasn't the first to market with a weight-loss drug in the emerging GLP-1 space. The first company was Novo Nordisk (NYSE: NVO), with Wegovy. But Novo Nordisk struggled to keep up with demand, and…...

6+ day, 7+ hour ago   (798+ words) Eli Lilly LLY and Johnson & Johnson JNJ are two leading U.S.-based healthcare companies with strong positions across the pharmaceutical and biotech industries. Both companies continue to deliver strong revenue and earnings growth and have promising long-term prospects. However, which stock…...

1+ week, 12+ hour ago   (416+ words) Griffin's Citadel Advisors and Druckenmiller's Duquesne Family Office bought Lilly stock in Q2. The billionaires likely capitalized on an opportunity with Lilly's shares tumbling early in the quarter. Lilly continues to generate strong revenue and earnings growth. The adage that "birds…...

1+ week, 4+ day ago   (196+ words) Lilly has acquired some 26 companies since 2023. Sales of its GLP-1 drug are funding the deals. This week, Eli Lilly(NYSE: LLY) announced a deal that will add to its already formidable drug pipeline. The company's leading therapy, MER511, is in Phase…...

1+ week, 5+ day ago   (483+ words) Eli Lilly (LLY) stock dipped after the company announced its latest deal in an ongoing acquisition spree. Lilly agreed to buy privately-held Merida Biosciences for $2.9 billion in cash. Merida’s lead candidate, MER511, is part of a pipeline of experimental biologic drugs…...

1+ week, 6+ day ago   (96+ words) Published on 08/31/2026 at 01:43 pm EDT Lilly has been on a record spending spree, having announced more than $20 billion in deals so far in 2026. The drugmaker has been using the windfall from its Zepbound and Mounjaro shots to diversify its pipeline,…...

1+ week, 5+ day ago   (672+ words) It has agreed to pay up to nearly $2.88 billion for a clinical-stage biotech. That company's uniqueness was a clear attraction for the pharmaceutical giant. Eli Lilly (NYSE:LLY) announced yet another acquisition on Monday. The American pharmaceutical giant has signed…...